nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—ESR1—Alzheimer's disease	0.176	0.627	CbGaD
Tamoxifen—SIGMAR1—Donepezil—Alzheimer's disease	0.171	0.399	CbGbCtD
Tamoxifen—CYP2D6—Alzheimer's disease	0.105	0.373	CbGaD
Tamoxifen—CYP2A6—Memantine—Alzheimer's disease	0.0615	0.144	CbGbCtD
Tamoxifen—CYP2B6—Memantine—Alzheimer's disease	0.0401	0.0936	CbGbCtD
Tamoxifen—CYP2D6—Rivastigmine—Alzheimer's disease	0.0279	0.0652	CbGbCtD
Tamoxifen—CYP2C19—Memantine—Alzheimer's disease	0.0255	0.0595	CbGbCtD
Tamoxifen—CYP2C9—Donepezil—Alzheimer's disease	0.0244	0.057	CbGbCtD
Tamoxifen—CYP2D6—Donepezil—Alzheimer's disease	0.0223	0.0521	CbGbCtD
Tamoxifen—CYP3A4—Rivastigmine—Alzheimer's disease	0.0178	0.0415	CbGbCtD
Tamoxifen—CYP2D6—Galantamine—Alzheimer's disease	0.0144	0.0336	CbGbCtD
Tamoxifen—CYP3A4—Donepezil—Alzheimer's disease	0.0142	0.0332	CbGbCtD
Tamoxifen—CYP3A4—Galantamine—Alzheimer's disease	0.00915	0.0214	CbGbCtD
Tamoxifen—SULT1A1—forebrain—Alzheimer's disease	0.0017	0.0423	CbGeAlD
Tamoxifen—SULT1A1—telencephalon—Alzheimer's disease	0.00156	0.0389	CbGeAlD
Tamoxifen—Diethylstilbestrol—TTR—Alzheimer's disease	0.0014	0.348	CrCbGaD
Tamoxifen—DHCR7—forebrain—Alzheimer's disease	0.00121	0.0301	CbGeAlD
Tamoxifen—FMO1—forebrain—Alzheimer's disease	0.00121	0.0301	CbGeAlD
Tamoxifen—EBPL—nervous system—Alzheimer's disease	0.00116	0.0289	CbGeAlD
Tamoxifen—EBPL—central nervous system—Alzheimer's disease	0.00112	0.0278	CbGeAlD
Tamoxifen—DHCR7—telencephalon—Alzheimer's disease	0.00111	0.0276	CbGeAlD
Tamoxifen—EBPL—cerebellum—Alzheimer's disease	0.00109	0.0272	CbGeAlD
Tamoxifen—ESR1—blood vessel—Alzheimer's disease	0.000928	0.0231	CbGeAlD
Tamoxifen—SULT1A1—nervous system—Alzheimer's disease	0.000923	0.0229	CbGeAlD
Tamoxifen—SULT1A1—central nervous system—Alzheimer's disease	0.000889	0.0221	CbGeAlD
Tamoxifen—EBPL—brain—Alzheimer's disease	0.000888	0.0221	CbGeAlD
Tamoxifen—SULT1A1—cerebellum—Alzheimer's disease	0.000869	0.0216	CbGeAlD
Tamoxifen—ESR2—forebrain—Alzheimer's disease	0.000715	0.0178	CbGeAlD
Tamoxifen—SULT1A1—brain—Alzheimer's disease	0.000706	0.0175	CbGeAlD
Tamoxifen—ESR2—telencephalon—Alzheimer's disease	0.000657	0.0163	CbGeAlD
Tamoxifen—DHCR7—nervous system—Alzheimer's disease	0.000657	0.0163	CbGeAlD
Tamoxifen—FMO1—nervous system—Alzheimer's disease	0.000657	0.0163	CbGeAlD
Tamoxifen—ESRRA—nervous system—Alzheimer's disease	0.000646	0.0161	CbGeAlD
Tamoxifen—DHCR7—central nervous system—Alzheimer's disease	0.000632	0.0157	CbGeAlD
Tamoxifen—FMO1—central nervous system—Alzheimer's disease	0.000632	0.0157	CbGeAlD
Tamoxifen—ESRRA—central nervous system—Alzheimer's disease	0.000622	0.0155	CbGeAlD
Tamoxifen—DHCR7—cerebellum—Alzheimer's disease	0.000618	0.0154	CbGeAlD
Tamoxifen—ESRRA—cerebellum—Alzheimer's disease	0.000608	0.0151	CbGeAlD
Tamoxifen—FMO3—nervous system—Alzheimer's disease	0.000567	0.0141	CbGeAlD
Tamoxifen—CYP19A1—forebrain—Alzheimer's disease	0.000563	0.014	CbGeAlD
Tamoxifen—ESR1—embryo—Alzheimer's disease	0.000553	0.0138	CbGeAlD
Tamoxifen—FMO3—central nervous system—Alzheimer's disease	0.000546	0.0136	CbGeAlD
Tamoxifen—SIGMAR1—telencephalon—Alzheimer's disease	0.000509	0.0127	CbGeAlD
Tamoxifen—FMO1—brain—Alzheimer's disease	0.000502	0.0125	CbGeAlD
Tamoxifen—DHCR7—brain—Alzheimer's disease	0.000502	0.0125	CbGeAlD
Tamoxifen—Dimetacrine—ACHE—Alzheimer's disease	0.000499	0.125	CrCbGaD
Tamoxifen—ESRRA—brain—Alzheimer's disease	0.000494	0.0123	CbGeAlD
Tamoxifen—ESR1—forebrain—Alzheimer's disease	0.000489	0.0122	CbGeAlD
Tamoxifen—CYP1B1—telencephalon—Alzheimer's disease	0.000484	0.012	CbGeAlD
Tamoxifen—ESR1—telencephalon—Alzheimer's disease	0.00045	0.0112	CbGeAlD
Tamoxifen—CES1—nervous system—Alzheimer's disease	0.000448	0.0111	CbGeAlD
Tamoxifen—FMO3—brain—Alzheimer's disease	0.000434	0.0108	CbGeAlD
Tamoxifen—CES1—central nervous system—Alzheimer's disease	0.000431	0.0107	CbGeAlD
Tamoxifen—ESR2—nervous system—Alzheimer's disease	0.000388	0.00964	CbGeAlD
Tamoxifen—Haemoglobin—Galantamine—Alzheimer's disease	0.000381	0.00259	CcSEcCtD
Tamoxifen—Hepatitis—Galantamine—Alzheimer's disease	0.000379	0.00258	CcSEcCtD
Tamoxifen—Haemorrhage—Galantamine—Alzheimer's disease	0.000379	0.00258	CcSEcCtD
Tamoxifen—Osteoarthritis—Rivastigmine—Alzheimer's disease	0.000377	0.00257	CcSEcCtD
Tamoxifen—Alanine aminotransferase increased—Donepezil—Alzheimer's disease	0.000375	0.00255	CcSEcCtD
Tamoxifen—Oedema peripheral—Galantamine—Alzheimer's disease	0.000374	0.00254	CcSEcCtD
Tamoxifen—ESR2—central nervous system—Alzheimer's disease	0.000373	0.00928	CbGeAlD
Tamoxifen—Influenza—Donepezil—Alzheimer's disease	0.000367	0.0025	CcSEcCtD
Tamoxifen—Dysphagia—Donepezil—Alzheimer's disease	0.000367	0.0025	CcSEcCtD
Tamoxifen—CYP2A6—cerebellum—Alzheimer's disease	0.000367	0.00912	CbGeAlD
Tamoxifen—ABCB1—blood vessel—Alzheimer's disease	0.000366	0.00911	CbGeAlD
Tamoxifen—Visual impairment—Galantamine—Alzheimer's disease	0.000365	0.00249	CcSEcCtD
Tamoxifen—Mood swings—Memantine—Alzheimer's disease	0.000365	0.00249	CcSEcCtD
Tamoxifen—ESR2—cerebellum—Alzheimer's disease	0.000365	0.00907	CbGeAlD
Tamoxifen—Blood creatinine increased—Memantine—Alzheimer's disease	0.000361	0.00246	CcSEcCtD
Tamoxifen—ABCG2—telencephalon—Alzheimer's disease	0.00036	0.00896	CbGeAlD
Tamoxifen—Pancreatitis—Donepezil—Alzheimer's disease	0.00036	0.00245	CcSEcCtD
Tamoxifen—Angina pectoris—Donepezil—Alzheimer's disease	0.000358	0.00243	CcSEcCtD
Tamoxifen—Mood swings—Rivastigmine—Alzheimer's disease	0.000358	0.00243	CcSEcCtD
Tamoxifen—Liver function test abnormal—Memantine—Alzheimer's disease	0.000356	0.00242	CcSEcCtD
Tamoxifen—Bronchitis—Donepezil—Alzheimer's disease	0.000353	0.0024	CcSEcCtD
Tamoxifen—Abdominal discomfort—Donepezil—Alzheimer's disease	0.000352	0.00239	CcSEcCtD
Tamoxifen—Flushing—Galantamine—Alzheimer's disease	0.000352	0.00239	CcSEcCtD
Tamoxifen—Liver function test abnormal—Rivastigmine—Alzheimer's disease	0.000348	0.00237	CcSEcCtD
Tamoxifen—Aspartate aminotransferase increased—Memantine—Alzheimer's disease	0.000347	0.00236	CcSEcCtD
Tamoxifen—CES1—brain—Alzheimer's disease	0.000342	0.00851	CbGeAlD
Tamoxifen—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.00034	0.00231	CcSEcCtD
Tamoxifen—Cramp muscle—Rivastigmine—Alzheimer's disease	0.00034	0.00231	CcSEcCtD
Tamoxifen—Arrhythmia—Galantamine—Alzheimer's disease	0.000339	0.0023	CcSEcCtD
Tamoxifen—Weight increased—Donepezil—Alzheimer's disease	0.000334	0.00227	CcSEcCtD
Tamoxifen—Influenza—Memantine—Alzheimer's disease	0.000333	0.00227	CcSEcCtD
Tamoxifen—Dysphagia—Memantine—Alzheimer's disease	0.000333	0.00227	CcSEcCtD
Tamoxifen—Weight decreased—Donepezil—Alzheimer's disease	0.000332	0.00226	CcSEcCtD
Tamoxifen—Pneumonia—Donepezil—Alzheimer's disease	0.000329	0.00224	CcSEcCtD
Tamoxifen—Pancreatitis—Memantine—Alzheimer's disease	0.000327	0.00222	CcSEcCtD
Tamoxifen—Depression—Donepezil—Alzheimer's disease	0.000326	0.00222	CcSEcCtD
Tamoxifen—Dysphagia—Rivastigmine—Alzheimer's disease	0.000326	0.00222	CcSEcCtD
Tamoxifen—Angina pectoris—Memantine—Alzheimer's disease	0.000325	0.00221	CcSEcCtD
Tamoxifen—Dysgeusia—Galantamine—Alzheimer's disease	0.000323	0.0022	CcSEcCtD
Tamoxifen—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000323	0.0022	CcSEcCtD
Tamoxifen—Myocardial infarction—Donepezil—Alzheimer's disease	0.000321	0.00218	CcSEcCtD
Tamoxifen—Bronchitis—Memantine—Alzheimer's disease	0.000321	0.00218	CcSEcCtD
Tamoxifen—Pancreatitis—Rivastigmine—Alzheimer's disease	0.00032	0.00218	CcSEcCtD
Tamoxifen—Back pain—Galantamine—Alzheimer's disease	0.000319	0.00217	CcSEcCtD
Tamoxifen—Urinary tract infection—Donepezil—Alzheimer's disease	0.000318	0.00216	CcSEcCtD
Tamoxifen—Angina pectoris—Rivastigmine—Alzheimer's disease	0.000318	0.00216	CcSEcCtD
Tamoxifen—Muscle spasms—Galantamine—Alzheimer's disease	0.000317	0.00216	CcSEcCtD
Tamoxifen—Pancytopenia—Memantine—Alzheimer's disease	0.000317	0.00215	CcSEcCtD
Tamoxifen—Sweating—Donepezil—Alzheimer's disease	0.000314	0.00214	CcSEcCtD
Tamoxifen—Bronchitis—Rivastigmine—Alzheimer's disease	0.000314	0.00213	CcSEcCtD
Tamoxifen—CYP2E1—telencephalon—Alzheimer's disease	0.000312	0.00776	CbGeAlD
Tamoxifen—Neutropenia—Memantine—Alzheimer's disease	0.000312	0.00212	CcSEcCtD
Tamoxifen—Erectile dysfunction—Memantine—Alzheimer's disease	0.000307	0.00209	CcSEcCtD
Tamoxifen—CYP19A1—nervous system—Alzheimer's disease	0.000306	0.0076	CbGeAlD
Tamoxifen—Anaemia—Galantamine—Alzheimer's disease	0.000305	0.00208	CcSEcCtD
Tamoxifen—Weight increased—Memantine—Alzheimer's disease	0.000303	0.00206	CcSEcCtD
Tamoxifen—Weight decreased—Memantine—Alzheimer's disease	0.000302	0.00205	CcSEcCtD
Tamoxifen—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.0003	0.00204	CcSEcCtD
Tamoxifen—Pneumonia—Memantine—Alzheimer's disease	0.000299	0.00203	CcSEcCtD
Tamoxifen—CYP2A6—brain—Alzheimer's disease	0.000298	0.00741	CbGeAlD
Tamoxifen—Weight increased—Rivastigmine—Alzheimer's disease	0.000297	0.00202	CcSEcCtD
Tamoxifen—ESR2—brain—Alzheimer's disease	0.000297	0.00737	CbGeAlD
Tamoxifen—Depression—Memantine—Alzheimer's disease	0.000296	0.00202	CcSEcCtD
Tamoxifen—Haemoglobin—Donepezil—Alzheimer's disease	0.000295	0.00201	CcSEcCtD
Tamoxifen—Weight decreased—Rivastigmine—Alzheimer's disease	0.000295	0.00201	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.000295	0.002	CcSEcCtD
Tamoxifen—CYP19A1—central nervous system—Alzheimer's disease	0.000294	0.00731	CbGeAlD
Tamoxifen—Hepatitis—Donepezil—Alzheimer's disease	0.000294	0.002	CcSEcCtD
Tamoxifen—Haemorrhage—Donepezil—Alzheimer's disease	0.000294	0.002	CcSEcCtD
Tamoxifen—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000293	0.00199	CcSEcCtD
Tamoxifen—Pneumonia—Rivastigmine—Alzheimer's disease	0.000293	0.00199	CcSEcCtD
Tamoxifen—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000292	0.00199	CcSEcCtD
Tamoxifen—Pharyngitis—Donepezil—Alzheimer's disease	0.000292	0.00198	CcSEcCtD
Tamoxifen—Myocardial infarction—Memantine—Alzheimer's disease	0.000291	0.00198	CcSEcCtD
Tamoxifen—Depression—Rivastigmine—Alzheimer's disease	0.00029	0.00197	CcSEcCtD
Tamoxifen—Oedema peripheral—Donepezil—Alzheimer's disease	0.00029	0.00197	CcSEcCtD
Tamoxifen—Urinary tract infection—Memantine—Alzheimer's disease	0.000289	0.00197	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000288	0.00196	CcSEcCtD
Tamoxifen—Cough—Galantamine—Alzheimer's disease	0.000288	0.00196	CcSEcCtD
Tamoxifen—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000287	0.00195	CcSEcCtD
Tamoxifen—CYP1B1—nervous system—Alzheimer's disease	0.000286	0.0071	CbGeAlD
Tamoxifen—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000285	0.00194	CcSEcCtD
Tamoxifen—Hypertension—Galantamine—Alzheimer's disease	0.000285	0.00194	CcSEcCtD
Tamoxifen—Visual impairment—Donepezil—Alzheimer's disease	0.000283	0.00193	CcSEcCtD
Tamoxifen—SIGMAR1—cerebellum—Alzheimer's disease	0.000283	0.00703	CbGeAlD
Tamoxifen—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000283	0.00192	CcSEcCtD
Tamoxifen—Myalgia—Galantamine—Alzheimer's disease	0.000281	0.00191	CcSEcCtD
Tamoxifen—Arthralgia—Galantamine—Alzheimer's disease	0.000281	0.00191	CcSEcCtD
Tamoxifen—Chest pain—Galantamine—Alzheimer's disease	0.000281	0.00191	CcSEcCtD
Tamoxifen—Anxiety—Galantamine—Alzheimer's disease	0.00028	0.00191	CcSEcCtD
Tamoxifen—Sinusitis—Memantine—Alzheimer's disease	0.000279	0.0019	CcSEcCtD
Tamoxifen—Sweating—Rivastigmine—Alzheimer's disease	0.000279	0.0019	CcSEcCtD
Tamoxifen—Loperamide—CALM1—Alzheimer's disease	0.000278	0.0694	CrCbGaD
Tamoxifen—Discomfort—Galantamine—Alzheimer's disease	0.000278	0.00189	CcSEcCtD
Tamoxifen—CYP1B1—central nervous system—Alzheimer's disease	0.000275	0.00684	CbGeAlD
Tamoxifen—Dry mouth—Galantamine—Alzheimer's disease	0.000275	0.00187	CcSEcCtD
Tamoxifen—Sinusitis—Rivastigmine—Alzheimer's disease	0.000273	0.00186	CcSEcCtD
Tamoxifen—CYP1B1—cerebellum—Alzheimer's disease	0.000269	0.00668	CbGeAlD
Tamoxifen—CYP2D6—forebrain—Alzheimer's disease	0.000269	0.00668	CbGeAlD
Tamoxifen—Haemoglobin—Memantine—Alzheimer's disease	0.000268	0.00182	CcSEcCtD
Tamoxifen—Haemorrhage—Memantine—Alzheimer's disease	0.000267	0.00182	CcSEcCtD
Tamoxifen—Hepatitis—Memantine—Alzheimer's disease	0.000267	0.00182	CcSEcCtD
Tamoxifen—ESR1—nervous system—Alzheimer's disease	0.000266	0.0066	CbGeAlD
Tamoxifen—Hypoaesthesia—Memantine—Alzheimer's disease	0.000266	0.00181	CcSEcCtD
Tamoxifen—Pharyngitis—Memantine—Alzheimer's disease	0.000265	0.0018	CcSEcCtD
Tamoxifen—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000264	0.00179	CcSEcCtD
Tamoxifen—Oedema peripheral—Memantine—Alzheimer's disease	0.000263	0.00179	CcSEcCtD
Tamoxifen—Arrhythmia—Donepezil—Alzheimer's disease	0.000263	0.00179	CcSEcCtD
Tamoxifen—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000262	0.00178	CcSEcCtD
Tamoxifen—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000261	0.00178	CcSEcCtD
Tamoxifen—Hepatitis—Rivastigmine—Alzheimer's disease	0.000261	0.00178	CcSEcCtD
Tamoxifen—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00026	0.00177	CcSEcCtD
Tamoxifen—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.00026	0.00177	CcSEcCtD
Tamoxifen—Alopecia—Donepezil—Alzheimer's disease	0.00026	0.00177	CcSEcCtD
Tamoxifen—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000259	0.00176	CcSEcCtD
Tamoxifen—Diethylstilbestrol—ESR1—Alzheimer's disease	0.000257	0.0642	CrCbGaD
Tamoxifen—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000257	0.00175	CcSEcCtD
Tamoxifen—Visual impairment—Memantine—Alzheimer's disease	0.000257	0.00175	CcSEcCtD
Tamoxifen—Anorexia—Galantamine—Alzheimer's disease	0.000257	0.00175	CcSEcCtD
Tamoxifen—Erythema—Donepezil—Alzheimer's disease	0.000256	0.00174	CcSEcCtD
Tamoxifen—ESR1—central nervous system—Alzheimer's disease	0.000256	0.00636	CbGeAlD
Tamoxifen—Erythema multiforme—Memantine—Alzheimer's disease	0.000252	0.00172	CcSEcCtD
Tamoxifen—Visual impairment—Rivastigmine—Alzheimer's disease	0.000252	0.00171	CcSEcCtD
Tamoxifen—Dysgeusia—Donepezil—Alzheimer's disease	0.000251	0.0017	CcSEcCtD
Tamoxifen—Ospemifene—ESR1—Alzheimer's disease	0.00025	0.0624	CrCbGaD
Tamoxifen—ESR1—cerebellum—Alzheimer's disease	0.00025	0.00621	CbGeAlD
Tamoxifen—Flushing—Memantine—Alzheimer's disease	0.000248	0.00168	CcSEcCtD
Tamoxifen—Back pain—Donepezil—Alzheimer's disease	0.000247	0.00168	CcSEcCtD
Tamoxifen—CYP2D6—telencephalon—Alzheimer's disease	0.000247	0.00614	CbGeAlD
Tamoxifen—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000247	0.00168	CcSEcCtD
Tamoxifen—Muscle spasms—Donepezil—Alzheimer's disease	0.000246	0.00167	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000245	0.00167	CcSEcCtD
Tamoxifen—Phenoxybenzamine—CALM1—Alzheimer's disease	0.000245	0.0611	CrCbGaD
Tamoxifen—Insomnia—Galantamine—Alzheimer's disease	0.000244	0.00166	CcSEcCtD
Tamoxifen—Flushing—Rivastigmine—Alzheimer's disease	0.000242	0.00165	CcSEcCtD
Tamoxifen—Paraesthesia—Galantamine—Alzheimer's disease	0.000242	0.00165	CcSEcCtD
Tamoxifen—Arrhythmia—Memantine—Alzheimer's disease	0.000238	0.00162	CcSEcCtD
Tamoxifen—Dyspepsia—Galantamine—Alzheimer's disease	0.000237	0.00161	CcSEcCtD
Tamoxifen—Anaemia—Donepezil—Alzheimer's disease	0.000236	0.00161	CcSEcCtD
Tamoxifen—Alopecia—Memantine—Alzheimer's disease	0.000236	0.0016	CcSEcCtD
Tamoxifen—Decreased appetite—Galantamine—Alzheimer's disease	0.000234	0.00159	CcSEcCtD
Tamoxifen—CYP19A1—brain—Alzheimer's disease	0.000234	0.00581	CbGeAlD
Tamoxifen—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000233	0.00159	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000233	0.00158	CcSEcCtD
Tamoxifen—Fatigue—Galantamine—Alzheimer's disease	0.000232	0.00158	CcSEcCtD
Tamoxifen—Alopecia—Rivastigmine—Alzheimer's disease	0.000231	0.00157	CcSEcCtD
Tamoxifen—Constipation—Galantamine—Alzheimer's disease	0.00023	0.00157	CcSEcCtD
Tamoxifen—SIGMAR1—brain—Alzheimer's disease	0.00023	0.00571	CbGeAlD
Tamoxifen—Dysgeusia—Memantine—Alzheimer's disease	0.000227	0.00155	CcSEcCtD
Tamoxifen—Erythema—Rivastigmine—Alzheimer's disease	0.000227	0.00155	CcSEcCtD
Tamoxifen—Back pain—Memantine—Alzheimer's disease	0.000225	0.00153	CcSEcCtD
Tamoxifen—Cough—Donepezil—Alzheimer's disease	0.000223	0.00152	CcSEcCtD
Tamoxifen—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000223	0.00151	CcSEcCtD
Tamoxifen—Hypertension—Donepezil—Alzheimer's disease	0.000221	0.0015	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00022	0.0015	CcSEcCtD
Tamoxifen—Back pain—Rivastigmine—Alzheimer's disease	0.00022	0.0015	CcSEcCtD
Tamoxifen—ABCB1—embryo—Alzheimer's disease	0.000219	0.00543	CbGeAlD
Tamoxifen—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000219	0.00149	CcSEcCtD
Tamoxifen—CYP1B1—brain—Alzheimer's disease	0.000218	0.00543	CbGeAlD
Tamoxifen—Arthralgia—Donepezil—Alzheimer's disease	0.000218	0.00148	CcSEcCtD
Tamoxifen—Chest pain—Donepezil—Alzheimer's disease	0.000218	0.00148	CcSEcCtD
Tamoxifen—Myalgia—Donepezil—Alzheimer's disease	0.000218	0.00148	CcSEcCtD
Tamoxifen—Anxiety—Donepezil—Alzheimer's disease	0.000217	0.00148	CcSEcCtD
Tamoxifen—Discomfort—Donepezil—Alzheimer's disease	0.000215	0.00146	CcSEcCtD
Tamoxifen—Anaemia—Memantine—Alzheimer's disease	0.000215	0.00146	CcSEcCtD
Tamoxifen—Dry mouth—Donepezil—Alzheimer's disease	0.000213	0.00145	CcSEcCtD
Tamoxifen—Abdominal pain—Galantamine—Alzheimer's disease	0.000213	0.00145	CcSEcCtD
Tamoxifen—Anaemia—Rivastigmine—Alzheimer's disease	0.00021	0.00143	CcSEcCtD
Tamoxifen—Oedema—Donepezil—Alzheimer's disease	0.000209	0.00142	CcSEcCtD
Tamoxifen—Leukopenia—Memantine—Alzheimer's disease	0.000208	0.00141	CcSEcCtD
Tamoxifen—Infection—Donepezil—Alzheimer's disease	0.000207	0.00141	CcSEcCtD
Tamoxifen—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000204	0.00139	CcSEcCtD
Tamoxifen—Toremifene—ESR1—Alzheimer's disease	0.000204	0.0509	CrCbGaD
Tamoxifen—ESR1—brain—Alzheimer's disease	0.000203	0.00505	CbGeAlD
Tamoxifen—Cough—Memantine—Alzheimer's disease	0.000203	0.00138	CcSEcCtD
Tamoxifen—CYP1A1—nervous system—Alzheimer's disease	0.000202	0.00502	CbGeAlD
Tamoxifen—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000202	0.00137	CcSEcCtD
Tamoxifen—Hypertension—Memantine—Alzheimer's disease	0.000201	0.00136	CcSEcCtD
Tamoxifen—ABCG2—cerebellum—Alzheimer's disease	0.0002	0.00498	CbGeAlD
Tamoxifen—Anorexia—Donepezil—Alzheimer's disease	0.000199	0.00135	CcSEcCtD
Tamoxifen—Hypersensitivity—Galantamine—Alzheimer's disease	0.000199	0.00135	CcSEcCtD
Tamoxifen—Cough—Rivastigmine—Alzheimer's disease	0.000198	0.00135	CcSEcCtD
Tamoxifen—Myalgia—Memantine—Alzheimer's disease	0.000198	0.00135	CcSEcCtD
Tamoxifen—Arthralgia—Memantine—Alzheimer's disease	0.000198	0.00135	CcSEcCtD
Tamoxifen—Chest pain—Memantine—Alzheimer's disease	0.000198	0.00135	CcSEcCtD
Tamoxifen—Anxiety—Memantine—Alzheimer's disease	0.000197	0.00134	CcSEcCtD
Tamoxifen—CYP2B6—nervous system—Alzheimer's disease	0.000196	0.00488	CbGeAlD
Tamoxifen—Hypertension—Rivastigmine—Alzheimer's disease	0.000196	0.00133	CcSEcCtD
Tamoxifen—Discomfort—Memantine—Alzheimer's disease	0.000195	0.00133	CcSEcCtD
Tamoxifen—CYP1A1—central nervous system—Alzheimer's disease	0.000195	0.00483	CbGeAlD
Tamoxifen—Myalgia—Rivastigmine—Alzheimer's disease	0.000193	0.00132	CcSEcCtD
Tamoxifen—Chest pain—Rivastigmine—Alzheimer's disease	0.000193	0.00132	CcSEcCtD
Tamoxifen—Arthralgia—Rivastigmine—Alzheimer's disease	0.000193	0.00132	CcSEcCtD
Tamoxifen—Dry mouth—Memantine—Alzheimer's disease	0.000193	0.00132	CcSEcCtD
Tamoxifen—Asthenia—Galantamine—Alzheimer's disease	0.000193	0.00131	CcSEcCtD
Tamoxifen—ABCB1—forebrain—Alzheimer's disease	0.000193	0.0048	CbGeAlD
Tamoxifen—Anxiety—Rivastigmine—Alzheimer's disease	0.000193	0.00131	CcSEcCtD
Tamoxifen—Discomfort—Rivastigmine—Alzheimer's disease	0.000191	0.0013	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00019	0.00129	CcSEcCtD
Tamoxifen—Oedema—Memantine—Alzheimer's disease	0.00019	0.00129	CcSEcCtD
Tamoxifen—Dry mouth—Rivastigmine—Alzheimer's disease	0.000189	0.00129	CcSEcCtD
Tamoxifen—CYP2B6—central nervous system—Alzheimer's disease	0.000189	0.0047	CbGeAlD
Tamoxifen—Insomnia—Donepezil—Alzheimer's disease	0.000189	0.00128	CcSEcCtD
Tamoxifen—Infection—Memantine—Alzheimer's disease	0.000188	0.00128	CcSEcCtD
Tamoxifen—Paraesthesia—Donepezil—Alzheimer's disease	0.000188	0.00128	CcSEcCtD
Tamoxifen—Dyspnoea—Donepezil—Alzheimer's disease	0.000186	0.00127	CcSEcCtD
Tamoxifen—Thrombocytopenia—Memantine—Alzheimer's disease	0.000186	0.00126	CcSEcCtD
Tamoxifen—Oedema—Rivastigmine—Alzheimer's disease	0.000185	0.00126	CcSEcCtD
Tamoxifen—Diarrhoea—Galantamine—Alzheimer's disease	0.000184	0.00125	CcSEcCtD
Tamoxifen—Infection—Rivastigmine—Alzheimer's disease	0.000184	0.00125	CcSEcCtD
Tamoxifen—CYP2E1—nervous system—Alzheimer's disease	0.000184	0.00458	CbGeAlD
Tamoxifen—Dyspepsia—Donepezil—Alzheimer's disease	0.000184	0.00125	CcSEcCtD
Tamoxifen—Hyperhidrosis—Memantine—Alzheimer's disease	0.000183	0.00125	CcSEcCtD
Tamoxifen—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000182	0.00124	CcSEcCtD
Tamoxifen—Decreased appetite—Donepezil—Alzheimer's disease	0.000182	0.00123	CcSEcCtD
Tamoxifen—Anorexia—Memantine—Alzheimer's disease	0.000181	0.00123	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00018	0.00123	CcSEcCtD
Tamoxifen—Fatigue—Donepezil—Alzheimer's disease	0.00018	0.00122	CcSEcCtD
Tamoxifen—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000179	0.00122	CcSEcCtD
Tamoxifen—Constipation—Donepezil—Alzheimer's disease	0.000179	0.00121	CcSEcCtD
Tamoxifen—Pain—Donepezil—Alzheimer's disease	0.000179	0.00121	CcSEcCtD
Tamoxifen—Dizziness—Galantamine—Alzheimer's disease	0.000178	0.00121	CcSEcCtD
Tamoxifen—ABCB1—telencephalon—Alzheimer's disease	0.000178	0.00442	CbGeAlD
Tamoxifen—CYP2E1—central nervous system—Alzheimer's disease	0.000177	0.00441	CbGeAlD
Tamoxifen—Anorexia—Rivastigmine—Alzheimer's disease	0.000177	0.0012	CcSEcCtD
Tamoxifen—Clomifene—ESR1—Alzheimer's disease	0.000176	0.044	CrCbGaD
Tamoxifen—CYP2E1—cerebellum—Alzheimer's disease	0.000173	0.00431	CbGeAlD
Tamoxifen—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000173	0.00117	CcSEcCtD
Tamoxifen—Insomnia—Memantine—Alzheimer's disease	0.000171	0.00117	CcSEcCtD
Tamoxifen—Vomiting—Galantamine—Alzheimer's disease	0.000171	0.00117	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000171	0.00116	CcSEcCtD
Tamoxifen—Paraesthesia—Memantine—Alzheimer's disease	0.00017	0.00116	CcSEcCtD
Tamoxifen—Rash—Galantamine—Alzheimer's disease	0.00017	0.00116	CcSEcCtD
Tamoxifen—Dermatitis—Galantamine—Alzheimer's disease	0.00017	0.00115	CcSEcCtD
Tamoxifen—Dyspnoea—Memantine—Alzheimer's disease	0.000169	0.00115	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000169	0.00115	CcSEcCtD
Tamoxifen—Headache—Galantamine—Alzheimer's disease	0.000169	0.00115	CcSEcCtD
Tamoxifen—Insomnia—Rivastigmine—Alzheimer's disease	0.000168	0.00114	CcSEcCtD
Tamoxifen—CYP2C8—brain—Alzheimer's disease	0.000167	0.00416	CbGeAlD
Tamoxifen—Dyspepsia—Memantine—Alzheimer's disease	0.000167	0.00114	CcSEcCtD
Tamoxifen—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000167	0.00113	CcSEcCtD
Tamoxifen—Urticaria—Donepezil—Alzheimer's disease	0.000166	0.00113	CcSEcCtD
Tamoxifen—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000165	0.00112	CcSEcCtD
Tamoxifen—Abdominal pain—Donepezil—Alzheimer's disease	0.000165	0.00112	CcSEcCtD
Tamoxifen—Decreased appetite—Memantine—Alzheimer's disease	0.000165	0.00112	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000164	0.00111	CcSEcCtD
Tamoxifen—Fatigue—Memantine—Alzheimer's disease	0.000163	0.00111	CcSEcCtD
Tamoxifen—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000163	0.00111	CcSEcCtD
Tamoxifen—ABCG2—brain—Alzheimer's disease	0.000163	0.00404	CbGeAlD
Tamoxifen—Pain—Memantine—Alzheimer's disease	0.000162	0.0011	CcSEcCtD
Tamoxifen—Constipation—Memantine—Alzheimer's disease	0.000162	0.0011	CcSEcCtD
Tamoxifen—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000161	0.0011	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00016	0.00109	CcSEcCtD
Tamoxifen—Nausea—Galantamine—Alzheimer's disease	0.00016	0.00109	CcSEcCtD
Tamoxifen—Fatigue—Rivastigmine—Alzheimer's disease	0.00016	0.00109	CcSEcCtD
Tamoxifen—Constipation—Rivastigmine—Alzheimer's disease	0.000159	0.00108	CcSEcCtD
Tamoxifen—Pain—Rivastigmine—Alzheimer's disease	0.000159	0.00108	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000155	0.00105	CcSEcCtD
Tamoxifen—CYP1A1—brain—Alzheimer's disease	0.000154	0.00384	CbGeAlD
Tamoxifen—Hypersensitivity—Donepezil—Alzheimer's disease	0.000154	0.00105	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000152	0.00103	CcSEcCtD
Tamoxifen—Urticaria—Memantine—Alzheimer's disease	0.000151	0.00102	CcSEcCtD
Tamoxifen—CYP2B6—brain—Alzheimer's disease	0.00015	0.00373	CbGeAlD
Tamoxifen—Abdominal pain—Memantine—Alzheimer's disease	0.00015	0.00102	CcSEcCtD
Tamoxifen—Asthenia—Donepezil—Alzheimer's disease	0.00015	0.00102	CcSEcCtD
Tamoxifen—CYP3A4—nervous system—Alzheimer's disease	0.000148	0.00368	CbGeAlD
Tamoxifen—Pruritus—Donepezil—Alzheimer's disease	0.000148	0.001	CcSEcCtD
Tamoxifen—Urticaria—Rivastigmine—Alzheimer's disease	0.000147	0.001	CcSEcCtD
Tamoxifen—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000147	0.000997	CcSEcCtD
Tamoxifen—CYP2D6—nervous system—Alzheimer's disease	0.000146	0.00363	CbGeAlD
Tamoxifen—Diarrhoea—Donepezil—Alzheimer's disease	0.000143	0.000972	CcSEcCtD
Tamoxifen—CYP3A4—central nervous system—Alzheimer's disease	0.000143	0.00355	CbGeAlD
Tamoxifen—CYP2E1—brain—Alzheimer's disease	0.000141	0.0035	CbGeAlD
Tamoxifen—CYP2D6—central nervous system—Alzheimer's disease	0.00014	0.00349	CbGeAlD
Tamoxifen—Hypersensitivity—Memantine—Alzheimer's disease	0.00014	0.00095	CcSEcCtD
Tamoxifen—Dizziness—Donepezil—Alzheimer's disease	0.000138	0.000939	CcSEcCtD
Tamoxifen—CYP2D6—cerebellum—Alzheimer's disease	0.000137	0.00341	CbGeAlD
Tamoxifen—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000137	0.00093	CcSEcCtD
Tamoxifen—Asthenia—Memantine—Alzheimer's disease	0.000136	0.000925	CcSEcCtD
Tamoxifen—Pruritus—Memantine—Alzheimer's disease	0.000134	0.000912	CcSEcCtD
Tamoxifen—Asthenia—Rivastigmine—Alzheimer's disease	0.000133	0.000905	CcSEcCtD
Tamoxifen—Vomiting—Donepezil—Alzheimer's disease	0.000133	0.000903	CcSEcCtD
Tamoxifen—Rash—Donepezil—Alzheimer's disease	0.000132	0.000896	CcSEcCtD
Tamoxifen—Dermatitis—Donepezil—Alzheimer's disease	0.000132	0.000895	CcSEcCtD
Tamoxifen—Pruritus—Rivastigmine—Alzheimer's disease	0.000131	0.000893	CcSEcCtD
Tamoxifen—Headache—Donepezil—Alzheimer's disease	0.000131	0.00089	CcSEcCtD
Tamoxifen—Diarrhoea—Memantine—Alzheimer's disease	0.00013	0.000882	CcSEcCtD
Tamoxifen—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000127	0.000863	CcSEcCtD
Tamoxifen—Tripelennamine—CYP2D6—Alzheimer's disease	0.000126	0.0315	CrCbGaD
Tamoxifen—Dizziness—Memantine—Alzheimer's disease	0.000125	0.000853	CcSEcCtD
Tamoxifen—Nausea—Donepezil—Alzheimer's disease	0.000124	0.000844	CcSEcCtD
Tamoxifen—Dizziness—Rivastigmine—Alzheimer's disease	0.000123	0.000834	CcSEcCtD
Tamoxifen—Vomiting—Memantine—Alzheimer's disease	0.000121	0.00082	CcSEcCtD
Tamoxifen—Rash—Memantine—Alzheimer's disease	0.00012	0.000813	CcSEcCtD
Tamoxifen—Dermatitis—Memantine—Alzheimer's disease	0.000119	0.000812	CcSEcCtD
Tamoxifen—Headache—Memantine—Alzheimer's disease	0.000119	0.000808	CcSEcCtD
Tamoxifen—Vomiting—Rivastigmine—Alzheimer's disease	0.000118	0.000802	CcSEcCtD
Tamoxifen—Rash—Rivastigmine—Alzheimer's disease	0.000117	0.000795	CcSEcCtD
Tamoxifen—Dermatitis—Rivastigmine—Alzheimer's disease	0.000117	0.000795	CcSEcCtD
Tamoxifen—Headache—Rivastigmine—Alzheimer's disease	0.000116	0.00079	CcSEcCtD
Tamoxifen—Cyclobenzaprine—HTR2A—Alzheimer's disease	0.000115	0.0286	CrCbGaD
Tamoxifen—Nausea—Memantine—Alzheimer's disease	0.000113	0.000766	CcSEcCtD
Tamoxifen—CYP2D6—brain—Alzheimer's disease	0.000112	0.00277	CbGeAlD
Tamoxifen—Nausea—Rivastigmine—Alzheimer's disease	0.00011	0.000749	CcSEcCtD
Tamoxifen—ABCB1—nervous system—Alzheimer's disease	0.000105	0.00261	CbGeAlD
Tamoxifen—Cyclobenzaprine—CYP2D6—Alzheimer's disease	0.000105	0.0262	CrCbGaD
Tamoxifen—ABCB1—central nervous system—Alzheimer's disease	0.000101	0.00251	CbGeAlD
Tamoxifen—ABCB1—cerebellum—Alzheimer's disease	9.88e-05	0.00245	CbGeAlD
Tamoxifen—ABCB1—brain—Alzheimer's disease	8.02e-05	0.00199	CbGeAlD
Tamoxifen—Diphenhydramine—PTGS1—Alzheimer's disease	7.32e-05	0.0183	CrCbGaD
Tamoxifen—Dextropropoxyphene—CYP2D6—Alzheimer's disease	7.09e-05	0.0177	CrCbGaD
Tamoxifen—Loperamide—CYP2D6—Alzheimer's disease	6.75e-05	0.0168	CrCbGaD
Tamoxifen—Diphenhydramine—CYP2D6—Alzheimer's disease	4.98e-05	0.0124	CrCbGaD
Tamoxifen—Methadone—CYP2D6—Alzheimer's disease	4.81e-05	0.012	CrCbGaD
Tamoxifen—Promazine—HTR2A—Alzheimer's disease	4.7e-05	0.0117	CrCbGaD
Tamoxifen—ESR1—Signaling Pathways—PRKCG—Alzheimer's disease	3.66e-06	3.66e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—CAV1—Alzheimer's disease	3.66e-06	3.66e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	3.66e-06	3.66e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ENO1—Alzheimer's disease	3.66e-06	3.66e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	3.65e-06	3.65e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—CAV1—Alzheimer's disease	3.63e-06	3.63e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	3.62e-06	3.62e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—MTHFR—Alzheimer's disease	3.61e-06	3.61e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—INS—Alzheimer's disease	3.6e-06	3.6e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PLCB1—Alzheimer's disease	3.6e-06	3.6e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ACHE—Alzheimer's disease	3.59e-06	3.59e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	3.59e-06	3.59e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	3.58e-06	3.58e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ENO1—Alzheimer's disease	3.57e-06	3.57e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTGS1—Alzheimer's disease	3.57e-06	3.57e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NGF—Alzheimer's disease	3.57e-06	3.57e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ACHE—Alzheimer's disease	3.56e-06	3.56e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	3.55e-06	3.55e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PPARGC1A—Alzheimer's disease	3.55e-06	3.55e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	3.55e-06	3.55e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PPARG—Alzheimer's disease	3.54e-06	3.54e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—HMOX1—Alzheimer's disease	3.53e-06	3.53e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	3.53e-06	3.53e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	3.52e-06	3.52e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	3.5e-06	3.5e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—A2M—Alzheimer's disease	3.5e-06	3.5e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ABCA1—Alzheimer's disease	3.49e-06	3.49e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PPARGC1A—Alzheimer's disease	3.48e-06	3.48e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CCR5—Alzheimer's disease	3.47e-06	3.47e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—INS—Alzheimer's disease	3.47e-06	3.47e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PPARGC1A—Alzheimer's disease	3.47e-06	3.47e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—HMOX1—Alzheimer's disease	3.46e-06	3.46e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—HMOX1—Alzheimer's disease	3.45e-06	3.45e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—BCHE—Alzheimer's disease	3.4e-06	3.4e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HTR2A—Alzheimer's disease	3.4e-06	3.4e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—CALM1—Alzheimer's disease	3.37e-06	3.37e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ENO1—Alzheimer's disease	3.37e-06	3.37e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	3.37e-06	3.37e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—APOE—Alzheimer's disease	3.36e-06	3.36e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ENO1—Alzheimer's disease	3.34e-06	3.34e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	3.34e-06	3.34e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—CAV1—Alzheimer's disease	3.33e-06	3.33e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—BCHE—Alzheimer's disease	3.32e-06	3.32e-05	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—AKT1—Alzheimer's disease	3.32e-06	3.32e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PPARGC1A—Alzheimer's disease	3.28e-06	3.28e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	3.27e-06	3.27e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—HMOX1—Alzheimer's disease	3.26e-06	3.26e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—LPL—Alzheimer's disease	3.23e-06	3.23e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PPARG—Alzheimer's disease	3.22e-06	3.22e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	3.21e-06	3.21e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PPARG—Alzheimer's disease	3.19e-06	3.19e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CALM1—Alzheimer's disease	3.17e-06	3.17e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—LPL—Alzheimer's disease	3.16e-06	3.17e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—NOS3—Alzheimer's disease	3.16e-06	3.16e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—LPL—Alzheimer's disease	3.16e-06	3.16e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—LEP—Alzheimer's disease	3.16e-06	3.16e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—APOE—Alzheimer's disease	3.16e-06	3.16e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—INS—Alzheimer's disease	3.16e-06	3.16e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	3.15e-06	3.15e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PLCB1—Alzheimer's disease	3.13e-06	3.13e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—BCHE—Alzheimer's disease	3.13e-06	3.13e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—INS—Alzheimer's disease	3.13e-06	3.13e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CAV1—Alzheimer's disease	3.13e-06	3.13e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	3.12e-06	3.12e-05	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—AKT1—Alzheimer's disease	3.12e-06	3.12e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	3.11e-06	3.11e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—BCHE—Alzheimer's disease	3.1e-06	3.1e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ACHE—Alzheimer's disease	3.04e-06	3.04e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—NOS3—Alzheimer's disease	3.04e-06	3.04e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ABCA1—Alzheimer's disease	3.04e-06	3.04e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—TPI1—Alzheimer's disease	3.03e-06	3.03e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CHAT—Alzheimer's disease	3.03e-06	3.03e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	3.01e-06	3.01e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	3e-06	3.01e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	2.99e-06	2.99e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—LPL—Alzheimer's disease	2.98e-06	2.98e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—F2—Alzheimer's disease	2.98e-06	2.98e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	2.95e-06	2.95e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	2.93e-06	2.93e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PPARG—Alzheimer's disease	2.92e-06	2.92e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NOTCH1—Alzheimer's disease	2.91e-06	2.91e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—MTHFR—Alzheimer's disease	2.91e-06	2.91e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—MAOB—Alzheimer's disease	2.9e-06	2.9e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PTGS2—Alzheimer's disease	2.89e-06	2.89e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.87e-06	2.87e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—INS—Alzheimer's disease	2.87e-06	2.87e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	2.86e-06	2.86e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	2.85e-06	2.85e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ENO1—Alzheimer's disease	2.85e-06	2.85e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—MTHFR—Alzheimer's disease	2.85e-06	2.85e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	2.84e-06	2.84e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	2.84e-06	2.84e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	2.8e-06	2.8e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	2.79e-06	2.8e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PTGS2—Alzheimer's disease	2.78e-06	2.78e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—NOS3—Alzheimer's disease	2.77e-06	2.77e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—NOS3—Alzheimer's disease	2.74e-06	2.74e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—LPL—Alzheimer's disease	2.74e-06	2.74e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—GSK3B—Alzheimer's disease	2.73e-06	2.73e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—CALM1—Alzheimer's disease	2.72e-06	2.72e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CREB1—Alzheimer's disease	2.71e-06	2.71e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—APOE—Alzheimer's disease	2.71e-06	2.71e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—A2M—Alzheimer's disease	2.7e-06	2.7e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—INS—Alzheimer's disease	2.7e-06	2.7e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—MTHFR—Alzheimer's disease	2.69e-06	2.69e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—CAV1—Alzheimer's disease	2.68e-06	2.68e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	2.68e-06	2.68e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	2.67e-06	2.67e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CALM1—Alzheimer's disease	2.66e-06	2.66e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CALM1—Alzheimer's disease	2.66e-06	2.66e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CCL2—Alzheimer's disease	2.65e-06	2.65e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—APOE—Alzheimer's disease	2.65e-06	2.65e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—BCHE—Alzheimer's disease	2.65e-06	2.65e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—APOE—Alzheimer's disease	2.65e-06	2.65e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CAV1—Alzheimer's disease	2.63e-06	2.63e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CAV1—Alzheimer's disease	2.62e-06	2.62e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	2.62e-06	2.62e-05	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—AKT1—Alzheimer's disease	2.61e-06	2.61e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IGF1—Alzheimer's disease	2.61e-06	2.61e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—HMOX1—Alzheimer's disease	2.61e-06	2.61e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PTGS2—Alzheimer's disease	2.53e-06	2.53e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—NOS3—Alzheimer's disease	2.51e-06	2.52e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—CALM1—Alzheimer's disease	2.51e-06	2.51e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PTGS2—Alzheimer's disease	2.51e-06	2.51e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	2.5e-06	2.5e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—APOE—Alzheimer's disease	2.5e-06	2.5e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—CAV1—Alzheimer's disease	2.48e-06	2.48e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	2.47e-06	2.47e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	2.46e-06	2.46e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	2.46e-06	2.46e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.45e-06	2.45e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	2.45e-06	2.45e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—LPL—Alzheimer's disease	2.44e-06	2.44e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	2.43e-06	2.43e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	2.42e-06	2.42e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—LPL—Alzheimer's disease	2.38e-06	2.38e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NOS3—Alzheimer's disease	2.37e-06	2.37e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PPARG—Alzheimer's disease	2.36e-06	2.36e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ACHE—Alzheimer's disease	2.35e-06	2.35e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	2.32e-06	2.32e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—INS—Alzheimer's disease	2.31e-06	2.31e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PPARG—Alzheimer's disease	2.31e-06	2.31e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PPARG—Alzheimer's disease	2.31e-06	2.31e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CALM1—Alzheimer's disease	2.3e-06	2.3e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PTGS2—Alzheimer's disease	2.3e-06	2.3e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—APOE—Alzheimer's disease	2.29e-06	2.29e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CAV1—Alzheimer's disease	2.27e-06	2.27e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—INS—Alzheimer's disease	2.27e-06	2.27e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—INS—Alzheimer's disease	2.26e-06	2.26e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—LPL—Alzheimer's disease	2.25e-06	2.25e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—LPL—Alzheimer's disease	2.23e-06	2.23e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	2.2e-06	2.2e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ENO1—Alzheimer's disease	2.2e-06	2.2e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	2.2e-06	2.2e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PPARG—Alzheimer's disease	2.18e-06	2.18e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	2.16e-06	2.16e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—MTHFR—Alzheimer's disease	2.15e-06	2.15e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—INS—Alzheimer's disease	2.14e-06	2.14e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	2.09e-06	2.09e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	2.08e-06	2.08e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CALM1—Alzheimer's disease	2.05e-06	2.05e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—APOE—Alzheimer's disease	2.05e-06	2.05e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—BCHE—Alzheimer's disease	2.05e-06	2.05e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—NOS3—Alzheimer's disease	2.03e-06	2.03e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CAV1—Alzheimer's disease	2.03e-06	2.03e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	2.02e-06	2.02e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CASP3—Alzheimer's disease	2.01e-06	2.01e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CALM1—Alzheimer's disease	2e-06	2.01e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	2e-06	2e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—APOE—Alzheimer's disease	2e-06	2e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PPARG—Alzheimer's disease	2e-06	2e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—NOS3—Alzheimer's disease	1.99e-06	1.99e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—NOS3—Alzheimer's disease	1.98e-06	1.98e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CAV1—Alzheimer's disease	1.98e-06	1.98e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—INS—Alzheimer's disease	1.96e-06	1.96e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.93e-06	1.93e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—AKT1—Alzheimer's disease	1.92e-06	1.93e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—LPL—Alzheimer's disease	1.9e-06	1.9e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CALM1—Alzheimer's disease	1.89e-06	1.89e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—APOE—Alzheimer's disease	1.88e-06	1.88e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—NOS3—Alzheimer's disease	1.87e-06	1.87e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CALM1—Alzheimer's disease	1.87e-06	1.87e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.87e-06	1.87e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—APOE—Alzheimer's disease	1.87e-06	1.87e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CAV1—Alzheimer's disease	1.86e-06	1.87e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PTGS2—Alzheimer's disease	1.86e-06	1.86e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CAV1—Alzheimer's disease	1.85e-06	1.85e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MAPK8—Alzheimer's disease	1.85e-06	1.85e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PTGS2—Alzheimer's disease	1.82e-06	1.82e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	1.81e-06	1.81e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PPARG—Alzheimer's disease	1.78e-06	1.78e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—INS—Alzheimer's disease	1.75e-06	1.75e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.74e-06	1.74e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—NOS3—Alzheimer's disease	1.72e-06	1.72e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PTGS2—Alzheimer's disease	1.71e-06	1.71e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	1.71e-06	1.71e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—INS—Alzheimer's disease	1.71e-06	1.71e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—VEGFA—Alzheimer's disease	1.7e-06	1.7e-05	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—AKT1—Alzheimer's disease	1.67e-06	1.67e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PPARG—Alzheimer's disease	1.64e-06	1.64e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PPARG—Alzheimer's disease	1.63e-06	1.63e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.61e-06	1.61e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—INS—Alzheimer's disease	1.61e-06	1.61e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.61e-06	1.61e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CALM1—Alzheimer's disease	1.6e-06	1.6e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.59e-06	1.59e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—INS—Alzheimer's disease	1.59e-06	1.59e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.58e-06	1.58e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	1.57e-06	1.57e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TGFB1—Alzheimer's disease	1.56e-06	1.56e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—NOS3—Alzheimer's disease	1.53e-06	1.53e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.5e-06	1.5e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.47e-06	1.47e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—AKT1—Alzheimer's disease	1.45e-06	1.45e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.41e-06	1.41e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	1.4e-06	1.4e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—AKT1—Alzheimer's disease	1.4e-06	1.4e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—NOS3—Alzheimer's disease	1.4e-06	1.4e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.39e-06	1.39e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.37e-06	1.37e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—INS—Alzheimer's disease	1.36e-06	1.36e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.32e-06	1.32e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.29e-06	1.29e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TP53—Alzheimer's disease	1.29e-06	1.29e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	1.28e-06	1.28e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—AKT1—Alzheimer's disease	1.27e-06	1.27e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—AKT1—Alzheimer's disease	1.26e-06	1.26e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.24e-06	1.24e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.23e-06	1.23e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.22e-06	1.22e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1.19e-06	1.19e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL6—Alzheimer's disease	1.18e-06	1.18e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—AKT1—Alzheimer's disease	1.16e-06	1.16e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	1.09e-06	1.09e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—AKT1—Alzheimer's disease	1.09e-06	1.09e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.07e-06	1.07e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—INS—Alzheimer's disease	1.05e-06	1.05e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—AKT1—Alzheimer's disease	9.33e-07	9.33e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NOS3—Alzheimer's disease	9.22e-07	9.22e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—AKT1—Alzheimer's disease	9.13e-07	9.14e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—AKT1—Alzheimer's disease	9.12e-07	9.12e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—AKT1—Alzheimer's disease	8.61e-07	8.61e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	8.43e-07	8.43e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—AKT1—Alzheimer's disease	7.9e-07	7.9e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—AKT1—Alzheimer's disease	7.05e-07	7.05e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—AKT1—Alzheimer's disease	6.88e-07	6.88e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—AKT1—Alzheimer's disease	6.48e-07	6.48e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—AKT1—Alzheimer's disease	6.43e-07	6.43e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—AKT1—Alzheimer's disease	5.49e-07	5.49e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—AKT1—Alzheimer's disease	4.24e-07	4.24e-06	CbGpPWpGaD
